Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin

Journal Article · · Cancer Res.; (United States)
OSTI ID:6446105
The feasibility of monitoring doses of 4-aminobiphenyl (ABP) via adduction to hemoglobin was investigated. Rats dosed with ABP (from 0.5 micrograms/kg to 5 mg/kg) formed a stable covalent hemoglobin:ABP adduct. Approximately 5% of a single dose was bound as hemoglobin:ABP; chronic dosing led to an accumulation of the adduct to a level 30 times greater than that found after a single dose. Facile in vitro hydrolysis of the adduct regenerated ABP, allowing detection at the sub-ng level. Human hemoglobin was also readily adducted, using N-hydroxy-ABP in vitro. The predominant site of adduction appeared to be the cysteine residue in hemoglobin. The use of such adducts as dosimeters for arylamine exposures in humans is discussed.
Research Organization:
Massachusetts Institute of Technology, Department of Nutrition and Food Science, Cambridge
OSTI ID:
6446105
Journal Information:
Cancer Res.; (United States), Journal Name: Cancer Res.; (United States) Vol. 44:10; ISSN CNREA
Country of Publication:
United States
Language:
English